First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors
Garrido-Laguna, Ignacio, Krop, Ian, Burris, Howard A., Hamilton, Erika, Braiteh, Fadi, Weise, Amy M., Abu-Khalaf, Maysa, Werner, Theresa L., Pirie-Shepherd, Steven, Zopf, Christopher J., LakshminarayaЖурнал:
International Journal of Cancer
DOI:
10.1002/ijc.32154
Date:
January, 2019
Файл:
PDF, 726 KB
2019
File converter
Більше результатів пошуку
More benefits 
